39174-87-3 Usage
Uses
Used in Organic Synthesis:
1-(3-nitro-5-(trifluoromethyl)phenyl)ethan-1-one is used as a key intermediate in the synthesis of various organic compounds. Its unique structural composition allows for further functionalization and modification, making it a valuable building block in the creation of complex organic molecules.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(3-nitro-5-(trifluoromethyl)phenyl)ethan-1-one is utilized as a starting material for the development of new pharmaceuticals. Its structural properties can be exploited to design and synthesize novel drug candidates with potential therapeutic applications.
Used in Agrochemicals:
1-(3-nitro-5-(trifluoromethyl)phenyl)ethan-1-one also finds application in the agrochemical industry, where it serves as a precursor for the synthesis of various agrochemicals, including pesticides and herbicides. Its unique chemical structure contributes to the development of effective and targeted agrochemical products.
Safety Precautions:
It is important to handle 1-(3-nitro-5-(trifluoromethyl)phenyl)ethan-1-one with care, as it may pose potential health and environmental hazards. Proper safety measures, including the use of personal protective equipment and adherence to safety protocols, should be taken to minimize risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 39174-87-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,1,7 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 39174-87:
(7*3)+(6*9)+(5*1)+(4*7)+(3*4)+(2*8)+(1*7)=143
143 % 10 = 3
So 39174-87-3 is a valid CAS Registry Number.
39174-87-3Relevant academic research and scientific papers
NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS
-
Page/Page column 96-97, (2018/07/29)
The present invention encompasses compounds of formula (I), wherein the groups R1 to R7 have the meanings given in the claims and specification, their use as inhibitors of SOS1, pharmaceutical compositions which contain compounds of this kind and their use as medicaments/medical uses, especially as agents for treatment and/or prevention of oncological diseases.
